Steris (STE) Land & Improvements (2025 - 2026)

Steris (STE) posted Land & Improvements of $112.5 million for Q2 2026, little changed on a QoQ basis from $112.3 million in Q1 2026.

Analysis

Steris (STE) Land & Improvements (2025 - 2026) Analysis & Trends

Steris has reported Land & Improvements for 2 years, with the latest figure at $112.5 million in Q2 2026.

On a quarterly basis, Land & Improvements changed N/A year-over-year to $112.5 million in Q2 2026; TTM through Jun 2026 was $112.5 million, a N/A change from a year earlier, with the FY2026 full-year figure at $112.3 million, up 5.84% from the prior year.
Land & Improvements was $112.5 million for Q2 2026 at Steris, roughly flat from $112.3 million in the prior quarter.
The five-year high for Land & Improvements was $112.5 million in Q2 2026, with the low at $106.1 million in Q1 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Land & Improvements (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	-
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	-
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	1.81 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	183.00 Mn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	-
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	-
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	-
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	112.50 Mn
10	Zimmer Biomet Holdings	18.20 Bn	17.79 Bn	1.54 Bn	-

Historic Data

Download Data